Patent: 10,172,817
✉ Email this page to a colleague
Summary for Patent: 10,172,817
Title: | Treatment and diagnosis of colon cancer |
Abstract: | The present invention discloses novel agents and methods for diagnosis and treatment of colon cancer. Also disclosed are related arrays, kits, and screening methods. |
Inventor(s): | Tavazoie; Sohail (New York, NY), Loo; Jia M. (New York, NY) |
Assignee: | The Rockefeller University (New York, NY) |
Application Number: | 15/630,024 |
Patent Claims: | see list of patent claims |
Details for Patent 10,172,817
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2032-10-31 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2032-10-31 |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2032-10-31 |
Sanofi-aventis U.s. Llc | ZALTRAP | ziv-aflibercept | Injection | 125418 | 08/03/2012 | ⤷ Try a Trial | 2032-10-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |